4.6 Article

Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development

Related references

Note: Only part of the references are listed.
Review Biochemical Research Methods

Computational approaches to therapeutic antibody design: established methods and emerging trends

Richard A. Norman et al.

BRIEFINGS IN BIOINFORMATICS (2020)

Article Medicine, General & Internal

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Pharmacology & Pharmacy

Recent advances of antibody drug conjugates for clinical applications

Pengxuan Zhao et al.

ACTA PHARMACEUTICA SINICA B (2020)

Article Medicine, General & Internal

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

G. von Minckwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Cell Biology

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

Kyoji Tsuchikama et al.

PROTEIN & CELL (2018)

Review Oncology

Antibody-drug conjugates-an emerging class of cancer treatment

Nikolaos Diamantis et al.

BRITISH JOURNAL OF CANCER (2016)

Article Medicine, General & Internal

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

Hagop M. Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Chemistry, Multidisciplinary

Current ADC Linker Chemistry

Nareshkumar Jain et al.

PHARMACEUTICAL RESEARCH (2015)

Review Oncology

Trastuzumab emtansine: mechanisms of action and drug resistance

Mark Barok et al.

BREAST CANCER RESEARCH (2014)

Review Oncology

Tetraspanin-enriched microdomains and hepatocellular carcinoma progression

Antonio Mazzocca et al.

CANCER LETTERS (2014)

Article Cell Biology

Tetraspanins at a glance

Stephanie Charrin et al.

JOURNAL OF CELL SCIENCE (2014)

Article Biochemistry & Molecular Biology

Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes

Dmitriy Mazurov et al.

FEBS JOURNAL (2013)

Review Oncology

Optimizing radioimmunoconjugate delivery in the treatment of solid tumor

Chen-Yu Huang et al.

CANCER TREATMENT REVIEWS (2012)

Article Biochemical Research Methods

An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis

Piia-Riitta Karhemo et al.

JOURNAL OF PROTEOMICS (2012)

Editorial Material Medicine, General & Internal

The Promise of Antibody-Drug Conjugates

Beverly A. Teicher et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

The Tetraspanins CD9 and CD81 Regulate CD9P1-Induced Effects on Cell Migration

Celia Chambrion et al.

PLOS ONE (2010)

Article Biochemistry & Molecular Biology

Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies

Anne-Laure Goenaga et al.

MOLECULAR IMMUNOLOGY (2007)

Article Biochemistry & Molecular Biology

Multiple levels of interactions within the tetraspanin web

S Charrin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Biochemical Research Methods

De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods

CS Gao et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2003)